Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

Share Price is delayed by 15 minutes
Get Live Data
317.50    0.50 (0.16%)
Bid:
315.50
Ask:
317.00
Spread: 1.50 (0.475%)
Market Cap: £732.37m
CSN Live PriceLast checked at - London Stock Exchange

Intraday Chesnara Share Chart

Interim Management Statement

19 May 2008 07:00

Chesnara plc

Interim Management Statement for the period from1 January 2008 to 16 May 2008

19 May 2008

This statement relates primarily to the financial position of Chesnara plc (the "Group") as at 31 March 2008 and to its financial performance during the first quarter. Where events and transactions have occurred since the first quarter end, which are estimated to have a material impact on management's core expectation of the financial position and/or financial performance of the Group, then these are identified together with a broad indication of their impact.

The key determinant of Group performance in the first quarter was the decline in global equity markets with the leading UK market indices showing an 11% decline over that period. The effect of this was a ‚£5m net of tax reduction to European Embedded Value ("EEV"). However subsequent recovery, particularly in the UK where markets have gained some 9% since the quarter end (to 16 May), implies a net of tax reduction in EEV over the whole period, due to investment market fluctuations, of some ‚£0.9m.

Apart from the impact of poor equity market performance in the first quarter the business is, based on fundamentals, performing slightly ahead of expectations. Key contributors are:

* Continuing favourable lapse experience across both our key protection and endowment products, offset by slightly higher mortality experience, which led to a net of tax EEV increase of some ‚£1m in the first quarter; * Endowment misselling complaints continue at relatively low levels with no significant change in uphold rates. Therefore the provision we hold continues to prove adequate; and * Expenses continue to be in line with management expectations.

The expected return from in-force business is also in line with expectations. The overall position at the quarter end is a reduction in EEV of some ‚£1.7m (net of tax) from ‚£187.3m to ‚£185.6m - both amounts are stated before adjustment for the proposed final dividend of ‚£10.3m. As indicated earlier, the market recovery since the quarter end has increased the EEV by some ‚£4.1m.

In contrast to the current volatility of the EEV, the IFRS result, which is impacted less by short-term market movements, of ‚£5.6m pre-tax (‚£4.7m net of tax) for the quarter has proved more resilient, and is broadly in line with management expectations.

The emergence of surplus from the life business has remained strong so that the ratio of regulatory capital resources to regulatory capital requirements in the life company has improved from 179% as at year-end to 206% at quarter end.

Whilst investment market performance has negatively affected the result to date this has been wholly mitigated by positive returns from other areas of the business.

The information in this release is based on management information.

Enquiries

Graham Kettleborough

Chief Executive, Chesnara Plc 07799 407519

Michael Henman

Cubitt Consulting 0207 367 5100

Notes to editors:

Chesnara plc, which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ("CA"). CA is a life assurance subsidiary that is substantially closed to new business. In June 2005 Chesnara acquired City of Westminster Assurance ("CWA") for ‚£47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Chesnara's operating model is to maintain a relatively small governance team and outsource the majority of its back office functions. Chesnara continues to seek acquisition opportunities in the financial services sector.

vendor
Date   Source Headline
23rd Nov 20177:30 amRNSHolding(s) in Company
23rd Nov 20177:00 amRNSResult of External Audit Tender
7th Nov 20177:00 amRNSDirector/PDMR Shareholding
1st Nov 20174:06 pmRNSTotal Voting Rights
7th Sep 20177:34 amRNSStatement re: the Legacy Review
31st Aug 20177:00 amRNSHalf-year Report
17th Aug 20174:00 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSNotice of Results
2nd Aug 20177:00 amRNSTotal Voting Rights
18th May 20177:00 amRNSResult of AGM
28th Apr 20173:26 pmRNSDirector/PDMR Shareholding
18th Apr 20177:00 amRNSAnnual Financial Report & AGM Notice
11th Apr 20172:06 pmRNSSCILDON - new name for Legal & General Nederland
6th Apr 20177:00 amRNSCompletion of LGN acquisition
31st Mar 20177:00 amRNSFinal Results
30th Mar 20175:15 pmRNSAcquisition
6th Mar 201712:11 pmRNSNotice of Results
6th Jan 20177:00 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSHolding(s) in Company
16th Dec 20164:56 pmRNSUpdate on Excess Applications
16th Dec 20162:15 pmRNSHolding(s) in Company
15th Dec 20168:00 amRNSAdmission of Shares
14th Dec 20167:00 amRNSDirectorate Change
13th Dec 20164:20 pmRNS2016 EGM Results, TVR and Director Dealing
13th Dec 20167:00 amRNSResults of Placing and Open Offer
24th Nov 20165:25 pmRNSPublication of a Prospectus
24th Nov 20167:01 amRNSProposed Acquisition and Placing
22nd Nov 20167:10 amRNSStatement regarding market speculation
22nd Nov 20167:00 amRNSStatement regarding press speculation
26th Oct 20167:00 amRNSDirectorate Change
29th Sep 201610:07 amRNSHolding(s) in Company
31st Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSHolding(s) in Company
10th Aug 201612:17 pmRNSNotice of Results
4th Jul 201610:32 amRNSHolding(s) in Company
14th Jun 20164:30 pmRNSNotification of director share interest
25th May 20161:41 pmRNSHolding(s) in Company
19th May 20167:00 amRNSDirectorate Change
19th May 20167:00 amRNSAppointment of new joint broker
19th May 20167:00 amRNSResult of AGM
28th Apr 20162:32 pmRNSDirector/PDMR Shareholding
20th Apr 20167:00 amRNSAnnual Financial Report 2015 and AGM Notice
31st Mar 20167:00 amRNSFinal Results
24th Mar 20168:45 amRNSNotice of Results
11th Mar 20163:45 pmRNSHolding(s) in Company
3rd Mar 20168:34 amRNSStatement re Legacy Review
30th Nov 20151:56 pmRNSHolding(s) in Company
19th Nov 20157:00 amRNSInterim Management Statement
13th Oct 20156:17 pmRNSHolding(s) in Company
28th Aug 20157:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.